12 results
Antiarrhythmic Medication Table

#Antiarrhythmic #Medications #Table #Classification #Classes #Cardiology #Pharmacology
Antiarrhythmic Medication ... Table #Antiarrhythmic ... #Medications #Table ... Classification #Classes ... #Cardiology #Pharmacology
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... Diabetes #Diabetic #Medications ... #Pharmacology # ... Dosing #Dosing # ... Impairment #CKD #Table
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
Summary of characteristics ... Antianginal Drugs DRUG CLASS ... #Antianginal #Medications ... #Cardiology #Pharmacology ... Management #Therapy #Table
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockers⠀
Class II
Antiarrhythmic Medications ... Classification - Summary ... Table Class I agents ... Classification #Summary ... #Table #pharmacology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
management #algorithm #pharmacology ... #treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology ... hematology #warfarin #dosing
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Summary of Pharmacology ... Treatments #Pharmacology ... #Dosing #Table ... Coronavirus #SARSCOV2 #Medications
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Subclasses, Mechanisms, Indications ... Channel #Blockers #ClassI ... #Na #cardiology ... #pharmacology # ... table #comparison
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... Summary Cardiac ... Transient K+ efflux moving ... inotropy) ACCP Cardiology ... Antiarrhythmics #Pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug Class ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... the use of this medication ... #Pharmacology #
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Cardiomyopathy - Summary ... exclude other causes ... Management during ... Delivery • Stable ... diagnosis #management #cardiology